Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Zahid, Muhammad Nauman
Foung, Steven K H
Zeisel, Mirjam B
Baumert, Thomas F
MetadataShow full item record
AbstractThe development of vaccines and other strategies to prevent hepatitis C virus (HCV) infection is limited by rapid viral evasion. HCV entry is the first step of infection; this process involves several viral and host factors and is targeted by host-neutralizing responses. Although the roles of host factors in HCV entry have been well characterized, their involvement in evasion of immune responses is poorly understood. We used acute infection of liver graft as a model to investigate the molecular mechanisms of viral evasion.
CitationMutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies. 2012, 143 (1):223-233.e9 Gastroenterology
AffiliationInserm, U748, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
The following license files are associated with this item:
- Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing Antibodies.
- Authors: Fauvelle C, Felmlee DJ, Crouchet E, Lee J, Heydmann L, Lefèvre M, Magri A, Hiet MS, Fofana I, Habersetzer F, Foung SK, Milne R, Patel AH, Vercauteren K, Meuleman P, Zeisel MB, Bartenschlager R, Schuster C, Baumert TF
- Issue date: 2016 Jan
- Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.
- Authors: Haberstroh A, Schnober EK, Zeisel MB, Carolla P, Barth H, Blum HE, Cosset FL, Koutsoudakis G, Bartenschlager R, Union A, Depla E, Owsianka A, Patel AH, Schuster C, Stoll-Keller F, Doffoël M, Dreux M, Baumert TF
- Issue date: 2008 Nov
- A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission.
- Authors: Fofana I, Xiao F, Thumann C, Turek M, Zona L, Tawar RG, Grunert F, Thompson J, Zeisel MB, Baumert TF
- Issue date: 2013
- Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
- Authors: Fafi-Kremer S, Fauvelle C, Felmlee DJ, Zeisel MB, Lepiller Q, Fofana I, Heydmann L, Stoll-Keller F, Baumert TF
- Issue date: 2012 Oct 9
- Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation.
- Authors: Fafi-Kremer S, Fofana I, Soulier E, Carolla P, Meuleman P, Leroux-Roels G, Patel AH, Cosset FL, Pessaux P, Doffoël M, Wolf P, Stoll-Keller F, Baumert TF
- Issue date: 2010 Aug 30